Facial hygiene and comprehensive management of rosacea

Cutis

Volumn 73, Issue 3, 2004, Pages 183-187

  Draelos, Zoe Diana ^a,b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONE; ALCOHOL; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ASTRINGENT AGENT; BENZOYL PEROXIDE; BISMUTH DERIVATIVE; BUTANEDIOL; CINNAMIC ACID; MENTHOL; METRONIDAZOLE; MICA; PERFUME; POLYETHYLENE; PROPYLENE GLYCOL; RETINOIC ACID; SHAMPOO; SILICON DIOXIDE; SOAP; SOLVENT; SULFACETAMIDE; SULFUR; SUNSCREEN; SURFACTANT; UREA;

CLINICAL FEATURE; DIETARY INTAKE; DISEASE CLASSIFICATION; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; ERYTHEMA; HUMAN; HYGIENE; LOTION; PRESCRIPTION; REVIEW; ROSACEA; SKIN ALLERGY; SKIN CARE; SKIN IRRITATION; SKIN SENSITIVITY;

DETERGENTS; HUMANS; HYGIENE; ROSACEA; SULFACETAMIDE;

EID: 1842558982     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Jansen T, Plewig G. Rosacea: classification and treatment. J R Soc Med. 1997;90:144-150.
2. Plewig G, Jansen T. Rosacea. In: Freedberg IM, Eisen AZ, Wolff K, et al, eds. Dermatology in General Medicine. 5th ed. New York, NY: McGraw-Hill; 1999:785-794.
3. Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol. 2002;46:584-587.
4. Dahl MV. Pathogenesis of rosacea. Adv Dermatol. 2001;17:29-45.
5. Marks R. Concepts in the pathogenesis of rosacea. Br J Dermatol. 1968;80:170-177.
6. Millikan L. The proposed inflammatory pathophysiology of rosacea: implications for treatment. Skinmed. 2003;2:43-47.
7. Wilkin JK. Flushing reactions: consequences and mechanisms. Ann Intern Med. 1981;95:468-476.
8. Guarrera M, Parodi A, Cipriani C, et al. Flushing in rosacea: a possible mechanism. Arch Dermatol Res. 1982;272:311-316.
9. Oztas MO, Balk M, Ogus E, et al. The role of free oxygen radicals in the aetiopathogenesis of rosacea. Clin Exp Dermatol. 2003;28:188-192.
10. Miyachi Y. Potential antioxidant mechanism of action for metronidazole: implications for rosacea management. Adv Ther. 2001;18:237-243.
11. Miyachi Y. Pharmacologic modulation of neutrophil functions. Clin Dermatol. 2000;18:369-373.
12. Georgala S, Katoulis AC, Kylafis GD, et al. Increased density of Demodex folliculorum and evidence of delayed hypersensitivity reaction in subjects with papulopustular rosacea. J Eur Acad Dermatol Venereol. 2001;15:441-444.
13. Bramford JT. Rosacea: current thoughts on origin. Semin Cutan Med Surg. 2001;20:199-206.
14. Draelos ZD. Clinical situations conducive to proactive barrier enhancement. Cutis. 2002;70(suppl 6):17-20.
15. Lonne-Rahm SB, Fischer T, Berg M. Stinging and rosacea. Acta Derm Venereol. 1999;79:460-461.
16. Corazza M, la Malfa W, Lombardi A, et al. Role of allergic contact dermatitis in rosacea. Contact Dermatitis. 1997;37:40-41.
17. Frosch PJ, Kligman AM. Recognition of chemically vulnerable and delicate skin. In: Frost P, Horwith SN, eds. Principles of Cosmetics for the Dermatologist. St Louis, Mo: Mosby; 1987:287-296.
18. Torok HM. Rosacea skin care. Cutis. 2000;66(suppl 4):14-16.
19. National Rosacea Society. Survey shows skin-care products, ingredients may aggravate rosacea. Rosacea Review. Summer 1997.
20. Scheman AJ. Cosmetic intolerance: choosing products for sensitive skin. Cosmet Dermatol. July 1999;12:28-30.
21. Bikowski J. The use of cleansers as therapeutic concomitants in various dermatologic disorders. Cutis. 2001;68(suppl 5):12-19.
22. Draelos ZD. Cosmetics in acne and rosacea. Semin Cutan Med Surg. 2001;20:209-214.
23. Wortzman MS. Evaluation of mild skin cleansers. Dermatol Clin. 1991;9:35-44.
24. Kirsner RS, Froelich CW. Soaps and detergents: understanding their composition and effect. Ostomy Wound Manage. 1998;44(suppl 3A):62S-70S.
25. Effendy I, Maibach HI. Detergent and skin irritation. Clin Dermatol. 1996;14:15-21.
26. Ertel K. Modern skin cleansers. Dermatol Clin. 2000;18:561-575.
27. Lippold BC. How to optimize drug penetration through the skin. Pharm Acta Helv. 1992;67:294-300.
28. Sauder DN, Miller R, Gratton D, et al. The treatment of rosacea: the safety and efficacy of sodium sulfacetamide 10% and sulfur 5% lotion (Novacet) is demonstrated in a double-blind study. J Dermatol Treat. 1997;8:79-85.
29. Tarimci N, Sener S, Kilinc T. Topical sodium sulfacetamide/sulfur lotion [letter]. J Clin Pharm Ther. 1997;22:301.